Chemical Diversion and Trafficking Act

Last updated
Chemical Diversion and Trafficking Act
Great Seal of the United States (obverse).svg
Other short titles
  • Alcoholic Beverage Labeling Act of 1988
  • Alcohol and Drug Traffic Safety Act of 1988
  • Anti-Drug Abuse Act of 1988
  • Asset Forfeiture Amendments Act of 1988
  • Bureau of Land Management Drug Enforcement Supplemental Authority Act
  • Child Protection and Obscenity Enforcement Act of 1988
  • Comprehensive Alcohol Abuse, Drug Abuse, and Mental Health Amendments Act of 1988
  • Drug-Free Public Housing Act of 1988
  • Drug-Free Workplace Act of 1988
  • Drunk Driving Prevention Act of 1988
  • Federal Aviation Administration Drug Enforcement Assistance Act of 1988
  • Insular Areas Drug Abuse Amendments of 1988
  • International Narcotics Control Act of 1988
  • Justice Department Organized Crime and Drug Enforcement Enhancement Act of 1988
  • Juvenile Justice and Delinquency Prevention Amendments of 1988
  • Minor and Technical Criminal Law Amendments Act of 1988
  • Money Laundering Prosecution Improvements Act of 1988
  • National Commission on Measured Responses to Achieve a Drug-Free America by 1995 Authorization Act
  • National Narcotics Leadership Act of 1988
  • Native Hawaiian Health Care Act of 1988
  • Public Housing Drug Elimination Act of 1988
  • Truck and Bus Safety and Regulatory Reform Act of 1988
  • Uniform Federal Crime Reporting Act of 1988
  • Urgent Supplemental Appropriations Act of 1989
Long titleAn Act to prevent the manufacturing, distribution, and use of illegal drugs, and for other purposes.
Acronyms (colloquial)CDTA, ADAAA
NicknamesAnti-Drug Abuse Amendments Act of 1988
Enacted bythe 100th United States Congress
EffectiveNovember 18, 1988
Citations
Public law 100-690
Statutes at Large 102  Stat.   4181 aka 102 Stat. 4312
Codification
Titles amended 21 U.S.C.: Food and Drugs
U.S.C. sections created
Legislative history

The Chemical Diversion and Trafficking Act of 1988 was an amendment to the Controlled Substances Act to regulate precursor chemicals, essential chemicals, tableting machines, and encapsulating machines by imposing record keeping and import/export reporting requirements on transactions involving these materials. Prior to these restrictions being put in place, the U.S. had been the primary source of chemicals used in South American cocaine manufacture. According to the DEA, the Act sharply reduced these precursor exports and cocaine manufacturers responded by purchasing from chemical suppliers outside the U.S. The U.S. in turn successfully lobbied for inclusion of chemical controls in the 1988 United Nations Convention Against Illicit Traffic in Narcotic Drugs and Psychotropic Substances, which included two Tables of controlled precursors.

Contents

Provisions of the Act

Short Title

The subtitle is cited as the Chemical Diversion and Trafficking Act of 1988.

Regulation of Listed Chemicals and Certain Machines

Controlled Substances Act is amended —
(a) (1) Each regulated person who engages in a regulated transaction involving a listed chemical, a tableting machine, or an encapsulating machine shall keep a record of the transaction —
(A) For 4 years after the date of the transaction, if the listed chemical is a precursor chemical or if the transaction involves a tableting machine or an encapsulating machine.
(B) For 2 years after the date of the transaction, if the listed chemical is an essential chemical.
(2) A record shall be retrievable and shall include the date of the regulated transaction, the identity of each party to the regulated transaction, a statement of the quantity and form of the listed chemical, a description of the tableting machine or encapsulating machine, and a description of the method of transfer. Such record shall be available for inspection and copying by the Attorney General.
(3) It is the duty of each regulated person who engages in a regulated transaction to identify each other party to the transaction. It is the duty of such other party to present proof of identity to the regulated person. The Attorney General shall specify by regulation the types of documents and other evidence that constitute proof of identity for purposes of this Act.
(b) Each regulated person shall report to the Attorney General, in such form and manner as the Attorney General shall prescribe by regulation —
(1) any regulated transaction involving an extraordinary quantity of a listed chemical, an uncommon method of payment or delivery, or any other circumstance that the regulated person believes may indicate that the listed chemical will be used in violation of this title
(2) any proposed regulated transaction with a person whose description or other identifying characteristic the Attorney General furnishes in advance to the regulated person
(3) any unusual or excessive loss or disappearance of a listed chemical under the control of the regulated person
(4) any regulated transaction in a tableting machine or an encapsulating machine
Each report shall be made at the earliest practicable opportunity after the regulated person becomes aware of the circumstance involved. A regulated person may not complete a transaction with a person whose description or identifying characteristic is furnished to the regulated person unless the transaction is approved by the Attorney General. The Attorney General shall make available to regulated persons guidance documents describing transactions and circumstances for which reports are required by this Act.
(c) (1) Except as provided, any information obtained by the Attorney General under this section which is exempt from disclosure under Title 5, United States Code, by reason of such title, is confidential and may not be disclosed to any person.
(2) Information referred to a regulated transaction involving a listed chemical, a tableting machine, or an encapsulating machine may be disclosed only —
(A) To an officer or employee of the United States engaged in carrying out this title, Title III, or the customs laws
(B) When relevant in any investigation or proceeding for the enforcement of this title, Title III, or the customs laws
(C) when necessary to comply with an obligation of the United States under a treaty or other international agreement
(D) to a State or local official or employee in conjunction with the enforcement of controlled substances laws or precursor chemical laws.
(3) The Attorney General shall —
(A) take such action as may be necessary to prevent unauthorized disclosure of information by any person to whom such information is disclosed under this Act
(B) issue guidelines that limit, to the maximum extent feasible, the disclosure of proprietary business information, including the names or identities of United States exporters of listed chemicals, to any person to whom such information is disclosed under this Act
(4) Any person who is aggrieved by a disclosure of information in violation of this section may bring a civil action against the violator for appropriate relief.
(5) Notwithstanding, a civil action may not be brought against investigative or law enforcement personnel of the Drug Enforcement Administration

Notification, Suspension of Shipment, and Penalties with Respect to Importation and Exportation of Listed Chemicals

(a) IN GENERAL — Controlled Substances Import and Export Act is amended
(a) Each regulated person who imports or exports a listed chemical shall notify the Attorney General of the importation or exportation not later than 15 days before the transaction is to take place.
(b) (1) Attorney General shall provide by regulation for circumstances in which the requirement does not apply to a transaction between a regulated person and a regular customer or regular supplier of the regulated person. At the time of any importation or exportation constituting a transaction referred to in the preceding sentence, the regulated person shall notify the Attorney General of the transaction.
(2) Regulations under this subsection shall provide that the initial notification with respect to a customer or supplier of a regulated person shall, upon the expiration of the 15-day period, qualify the customer as a regular customer or regular supplier, unless the Attorney General otherwise notifies the regulated person in writing.
(c) (1) Attorney General may order the suspension of any Commerce and importation or exportation of a listed chemical or may disqualify any regular customer or regular supplier on the ground that the chemical may be diverted to the clandestine manufacture of a controlled substance. From and after the time when the Attorney General provides written notice of the order (including a statement of the legal and factual basis for the order) to the regulated person, the regulated person may not carry out the transaction.
(2) Upon written request to the Attorney General, a regulated person to whom an order applies is entitled to an agency hearing on the record in accordance with subchapter II of chapter 5 of Title 5, United States Code. The hearing shall be held on an expedited basis and not later than 45 days after the request is made, except that the hearing may be held at a later time, if so requested by the regulated person.
(b) EFFECTIVE DATES AND SPECIAL RULES —
(1) Not later than 45, days after the date of the enactment of this Act, the Attorney General shall forward to the Director of the Office of Management and Budget proposed regulations required by the amendment.
(2) Not later than 55 days after the date of the enactment of this Act, the Director of the Office of Management and Budget shall —
(A) review such proposed regulations of the Attorney General
(B) forward any comments and recommendations for modifications to the Attorney General.
(3) Not later than 60 days after the date of the enactment of this Act, the Attorney General shall publish the proposed final regulations required by the amendment.
(4) Not later than 120 days after the date of the enactment of this Act, the Attorney General shall promulgate final regulations required by the amendment.
(5) Section 1018 of the Controlled Substances Import and Export Act shall take effect 90 days after the promulgation of the final regulations.
(6) Each regulated person shall provide to the Attorney General the identity of any regular customer or regular supplier of the regulated person not later than 30 days after the promulgation of the final regulations. Not later than 60 days after the end of such 30-day period, each regular customer and regular supplier so identified shall be a regular customer or regular supplier for purposes of any applicable exception from the requirement unless the Attorney General otherwise notifies the regulated person in writing.
(c) PENALTY FOR IMPORTATION OR EXPORTATION —
Controlled Substances Import and Export Act is amended —
(d) Any person who knowingly or intentionally —
(1) imports or exports a listed chemical with intent to manufacture a controlled substance in violation of this title or, in the case of an exportation, in violation of the law of the country to which the chemical is exported.
(2) imports or exports a listed chemical knowing, or having reasonable cause to believe, that the listed chemical will be used to manufacture a controlled substance in violation of this title or, in the case of an exportation, in violation of the law of the country to which the chemical is exported shall be fined in accordance with Title 18, United States Code, or imprisoned not more than 10 years, or both.

Definitions

Controlled Substances Act is amended —
The term 'listed precursor chemical' means a chemical specified by regulation of the Attorney General as a chemical that is used in manufacturing a controlled substance in violation of this title and is critical to the creation of the controlled substances, and such term includes (until otherwise specified by regulation of the Attorney General, as considered appropriate by the Attorney General or upon petition to the Attorney General by any person) the following:
(A) Anthranilic acid and its salts
(B) Benzyl cyanide
(C) Ephedrine, its salts, optical isomers, and salts of optical isomers
(D) Ergonovine and its salts
(E) Ergotamine and its salts
(F) N-Acetylanthranilic acid and its salts
(G) Norpseudoephedrine, its salts, optical isomers, and salts of optical isomers
(H) Phenylacetic acid and its salts
(I) Phenylpropanolamine, its salts, optical isomers, and salts of optical isomers
(J) Piperidine and its salts
(K) Pseudoephedrine, its salts, optical isomers, and salts of optical isomers
(L) 3,4-Methylenedioxyphenyl-2-propanone
The term 'listed essential chemical' means a chemical specified by regulation of the Attorney General as a chemical that is used as a solvent, reagent, or catalyst in manufacturing a controlled substance in violation of this title, and such term includes (until otherwise specified by regulation of the Attorney General, as considered appropriate by the Attorney General or upon petition to the Attorney General by any person) the following chemicals:
(A) Acetic anhydride
(B) Acetone
(C) Benzyl chloride
(D) Ethyl ether
(E) Hydriodic acid
(F) Potassium permanganate
(G) 2-Butanone
(H) Toluene
The term 'regular customer' means, with respect to a regulated person, a customer with whom the regulated person has an established business relationship that is reported to the Attorney General.
The term 'regular supplier' means, with respect to a regulated person, a supplier with whom the regulated person has an established business relationship that is reported to the Attorney General.
The term 'regulated person' means a person who manufactures, distributes, imports, or exports a listed chemical, a tableting machine, or an encapsulating machine.
The term 'regulated transaction' means —
(A) a distribution, receipt, sale, importation or exportation of a threshold amount, including a cumulative threshold amount for multiple transactions (as determined by the Attorney General, in consultation with the chemical industry and taking into consideration the quantities normally used for lawful purposes), of a listed chemical, except that such term does not include —
(I) a domestic lawful distribution in the usual course of business between agents or employees of a single regulated person
(II) a delivery of a listed chemical to or by a common or contract carrier for carriage in the lawful and usual course of the business of the common or contract carrier, or to or by a warehouseman for storage in the lawful and usual course of the business of the warehouseman, except that if the carriage or storage is in connection with the distribution, importation, or exportation of a listed chemical to a third person, this clause does not relieve a distributor, importer, or exporter from compliance with section 310.
(III) any category of transaction specified by regulation of the Attorney General (as excluded from this definition as unnecessary for enforcement of this title or Title III)
(IV) any transaction in a listed chemical that is contained in a drug that may be marketed or distributed lawfully in the United States under the Federal Food, Drug, and Cosmetic Act
(V) any transaction in a chemical mixture
(B) a distribution, importation, or exportation of a tableting machine or encapsulating machine
The term 'chemical mixture' means a combination of two or more chemical substances, at least one of which is not a listed precursor chemical or a listed essential chemical, except that such term does not include any combination of a listed precursor chemical or a listed essential chemical with another chemical that is present solely as an impurity.

Chemical Diversion Control Program

Controlled Substances Act is amended —
The Attorney General shall maintain an active program, both domestic and international, to curtail the diversion of precursor chemicals and essential chemicals used in the illicit manufacture of controlled substances.

See also

Related Research Articles

<span class="mw-page-title-main">Controlled Substances Act</span> United States drug-regulating law

The Controlled Substances Act (CSA) is the statute establishing federal U.S. drug policy under which the manufacture, importation, possession, use, and distribution of certain substances is regulated. It was passed by the 91st United States Congress as Title II of the Comprehensive Drug Abuse Prevention and Control Act of 1970 and signed into law by President Richard Nixon. The Act also served as the national implementing legislation for the Single Convention on Narcotic Drugs.

<span class="mw-page-title-main">Narcotic</span> Chemical substance with psycho-active properties

The term narcotic originally referred medically to any psychoactive compound with numbing or paralyzing properties. In the United States, it has since become associated with opiates and opioids, commonly morphine and heroin, as well as derivatives of many of the compounds found within raw opium latex. The primary three are morphine, codeine, and thebaine.

<span class="mw-page-title-main">Pseudoephedrine</span> Pharmaceutical drug

Pseudoephedrine (PSE) is a sympathomimetic drug of the phenethylamine and amphetamine chemical classes. It may be used as a nasal/sinus decongestant, as a stimulant, or as a wakefulness-promoting agent in higher doses.

<span class="mw-page-title-main">Ephedrine</span> Medication and stimulant

Ephedrine is a central nervous system (CNS) stimulant that is often used to prevent low blood pressure during anesthesia. It has also been used for asthma, narcolepsy, and obesity but is not the preferred treatment. It is of unclear benefit in nasal congestion. It can be taken by mouth or by injection into a muscle, vein, or just under the skin. Onset with intravenous use is fast, while injection into a muscle can take 20 minutes, and by mouth can take an hour for effect. When given by injection it lasts about an hour and when taken by mouth it can last up to four hours.

<span class="mw-page-title-main">Over-the-counter drug</span> Medication available without a prescription

Over-the-counter (OTC) drugs are medicines sold directly to a consumer without a requirement for a prescription from a healthcare professional, as opposed to prescription drugs, which may be supplied only to consumers possessing a valid prescription. In many countries, OTC drugs are selected by a regulatory agency to ensure that they contain ingredients that are safe and effective when used without a physician's care. OTC drugs are usually regulated according to their active pharmaceutical ingredient (API) rather than final products. By regulating APIs instead of specific drug formulations, governments allow manufacturers the freedom to formulate ingredients, or combinations of ingredients, into proprietary mixtures.

<span class="mw-page-title-main">HU-210</span> Chemical compound

HU-210 is a synthetic cannabinoid that was first synthesized in 1988 from (1R,5S)-myrtenol by a group led by Raphael Mechoulam at the Hebrew University. HU-210 is 100 to 800 times more potent than natural THC from cannabis and has an extended duration of action. HU-210 has a binding affinity of 0.061nM at CB1 and 0.52nM at CB2 in cloned human cannabinoid receptors compared to Delta-9-THC of 40.7nM at CB1. HU-210 is the (–)-1,1-dimethylheptyl analog of 11-hydroxy- Δ8- tetrahydrocannabinol; in some references it is called 1,1-dimethylheptyl- 11-hydroxytetrahydrocannabinol. The abbreviation "HU" stands for Hebrew University.

The United States Drug Enforcement Administration (DEA) maintains lists regarding the classification of illicit drugs. It also maintains List I of chemicals and List II of chemicals, which contain chemicals that are used to manufacture the controlled substances/illicit drugs. The list is designated within the Controlled Substances Act but can be modified by the U.S. Attorney General as illegal manufacturing practices change.

A controlled substance is generally a drug or chemical whose manufacture, possession and use is regulated by a government, such as illicitly used drugs or prescription medications that are designated by law. Some treaties, notably the Single Convention on Narcotic Drugs, the Convention on Psychotropic Substances, and the United Nations Convention Against Illicit Traffic in Narcotic Drugs and Psychotropic Substances, provide internationally agreed-upon "schedules" of controlled substances, which have been incorporated into national laws; however, national laws usually significantly expand on these international conventions.

<span class="mw-page-title-main">Controlled Substances Penalties Amendments Act of 1984</span>

The Controlled Substances Penalties Amendments Act of 1984, 98 Stat. 2068, generally enhanced the penalties for violations of the Comprehensive Drug Abuse Prevention and Control Act of 1970. The 1984 legislation removed an ambiguity in the then-existing law by providing that a State drug felony conviction would trigger the provisions enhancing penalties for recidivists; it went further by providing that a Foreign drug felony conviction would have the same effect. Finally, the 1984 legislation doubled the penalties for distribution of controlled substances where the offense is committed on or within 1,000 feet of school property.

The USA PATRIOT Act was passed by the United States Congress in 2001 as a response to the September 11, 2001 attacks. It has ten titles, each containing numerous sections. Title III: International Money Laundering Abatement and Financial Anti-Terrorism Act of 2001 is actually an act of Congress in its own right as well as being a title of the USA PATRIOT Act, and is intended to facilitate the prevention, detection and prosecution of international money laundering and the financing of terrorism. The title's sections primarily amend portions of the Money Laundering Control Act of 1986 and the Bank Secrecy Act of 1970.

<span class="mw-page-title-main">Control of Substances Hazardous to Health Regulations 2002</span> United Kingdom legislation

The Control of Substances Hazardous to Health Regulations 2002 is a United Kingdom Statutory Instrument which states general requirements imposed on employers to protect employees and other persons from the hazards of substances used at work by risk assessment, control of exposure, health surveillance and incident planning. There are also duties on employees to take care of their own exposure to hazardous substances and prohibitions on the import of certain substances into the European Economic Area. The regulations reenacted, with amendments, the Control of Substances Hazardous to Work Regulations 1999 and implement several European Union directives.

<span class="mw-page-title-main">Combat Methamphetamine Epidemic Act of 2005</span> US law

The Combat Methamphetamine Epidemic Act of 2005 (CMEA) is federal legislation enacted in the United States on March 9, 2006, to regulate, among other things, retail over-the-counter sales of following products because of their use in the manufacture of illegal drugs:

Amateur chemistry or home chemistry is the pursuit of chemistry as a private hobby. Amateur chemistry is usually done with whatever chemicals are available at disposal at the privacy of one's home. It should not be confused with clandestine chemistry, which involves the illicit production of controlled drugs. Notable amateur chemists include Oliver Sacks and Sir Edward Elgar.

<span class="mw-page-title-main">Convention on Psychotropic Substances</span> 1971 UN treaty to regulate recreational drugs

The Convention on Psychotropic Substances of 1971 is a United Nations treaty designed to control psychoactive drugs such as amphetamine-type stimulants, barbiturates, benzodiazepines, and psychedelics signed in Vienna, Austria on 21 February 1971. The Single Convention on Narcotic Drugs of 1961 did not ban the many newly discovered psychotropics, since its scope was limited to drugs with cannabis, coca and opium-like effects.

Kashinhou (化審法), short for 化学物質の審査及び製造等の規制に関する法律, is the current Chemicals and dangerous substances regulation law in Japan. The more concise abbreviated name is 化学物質審査規制法, or "Chemical Substances Control Law". This law featured the world's first new chemical pre-examination system.

<span class="mw-page-title-main">Cannabicyclohexanol</span> Chemical compound

Cannabicyclohexanol is a cannabinoid receptor agonist drug, developed by Pfizer in 1979. On 19 January 2009, the University of Freiburg in Germany announced that an analog of CP 47,497 was the main active ingredient in the herbal incense product Spice, specifically the 1,1-dimethyloctyl homologue of CP 47,497, which is now known as cannabicyclohexanol. The 1,1-dimethyloctyl homologue of CP 47,497 is in fact several times more potent than the parent compound, which is somewhat unexpected as the 1,1-dimethylheptyl is the most potent substituent in classical cannabinoid compounds such as HU-210.

<span class="mw-page-title-main">HU-243</span> Chemical compound with similarities to canbisol

HU-243 (AM-4056) is a synthetic cannabinoid drug that is a single enantiomer of the hydrogenated derivative of the commonly used reference agonist HU-210. It is a methylene homologue of canbisol. It is a potent agonist at both the CB1 and CB2 receptors, with a binding affinity of 0.041 nM at the CB1 receptor, making it marginally more potent than HU-210, which had an affinity of 0.061 nM in the same assay.

<span class="mw-page-title-main">Comprehensive Methamphetamine Control Act of 1996</span> US law

The Comprehensive Methamphetamine Control Act of 1996 is a bill enacted into law by the 104th Congress of the United States. It mandated registration of persons trading in list I chemicals from the DEA list of chemicals. A fee for such registration was initially $595 but later reduced to $116. It is regarded as one of the major drug laws in the United States.

<span class="mw-page-title-main">Section 125 of the Constitution Act, 1867</span> Provision of the Canadian Constitution

Section 125 of the Constitution Act, 1867 is a provision of the Constitution of Canada relating to taxation immunities of the federal and provincial governments. The section provides that the property of the provincial and federal governments are not subject to taxation.

<span class="mw-page-title-main">Designer Anabolic Steroid Control Act of 2014</span>

The Designer Anabolic Steroid Control Act of 2014 is a bill that expanded the list of anabolic steroids regulated by the Drug Enforcement Administration (DEA) to include about two dozen new substances and established new crimes relating to false labeling of steroids. The bill established a penalty of up to $500,000 against those found to be falsely labeling their anabolic steroid products.

References